Literature DB >> 4399664

A fraction of the ventricular myocardium that has the specificity of the cardiac beta-adrenergic receptor.

R J Lefkowitz, E Haber.   

Abstract

The 78,000 x g microsomal fraction of canine ventricular myocardium effected a 20-fold concentration of [(3)H]norepinephrine from a 10(-9) M solution. The [(3)H]norepinephrine bound was displaced by physiologic concentrations of the beta-adrenergic catecholamines isoproterenol, epinephrine, and norepinephrine, in that order, which is the order of effectiveness of their actions on the force and rate of cardiac contraction. Alpha-adrenergic compounds did not displace [(3)H]norepinephrine until concentrations four orders of magnitude greater were reached. The beta-adrenergic blocker propranolol displaced at 10(-6) M, whereas the alpha-adrenergic blocker phentolamine was inactive. Metabolites of the catecholamines did not compete for this binding site. It is concluded that, on the basis of specificity and affinity of binding, these microsomal particles are likely to contain the beta-adrenergic receptor.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4399664      PMCID: PMC389290          DOI: 10.1073/pnas.68.8.1773

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  CHARACTERISTICS OF NOREPINEPHRINE RETENTION BY A SUBCELLULAR FRACTION OF RABBIT HEART.

Authors:  C N GILLIS
Journal:  J Pharmacol Exp Ther       Date:  1964-10       Impact factor: 4.030

2.  Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver.

Authors:  F MURAD; Y M CHI; T W RALL; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1962-04       Impact factor: 5.157

3.  Adenyl cyclase and cyclic AMP. Biochemical links in the regulation of myocardial contractility.

Authors:  S E Epstein; G S Levey; C L Skelton
Journal:  Circulation       Date:  1971-03       Impact factor: 29.690

4.  Effect of directly and indirectly acting sympathomimetic amines on adrenergic transmitter granules.

Authors:  U S von Euler; F Lishajko
Journal:  Acta Physiol Scand       Date:  1968 May-Jun

Review 5.  Some factors affecting catecholamine uptake, storage, and release in adrenergic nerve granules.

Authors:  U S Von Euler
Journal:  Circ Res       Date:  1967-12       Impact factor: 17.367

Review 6.  Adenyl cyclase as an adrenergic receptor.

Authors:  G A Robison; R W Butcher; E W Sutherland
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

7.  Uptake and metabolism of dl-norepinephrine by subcellular particles of rat heart.

Authors:  I A Michaelson; P W Taylor; K C Richardson; E Titus
Journal:  J Pharmacol Exp Ther       Date:  1968-04       Impact factor: 4.030

8.  Inhibitory action of adrenergic blocking agents on reuptake and net uptake of noradrenaline in nerve granules.

Authors:  U S von Euler; F Lishajko
Journal:  Acta Physiol Scand       Date:  1968-11

9.  Hormone action at the membrane level. II. The binding of epinephrine and glucagon to the rat liver plasma membrane.

Authors:  V Tomasi; S Koretz; T K Ray; J Dunnick; G V Marinetti
Journal:  Biochim Biophys Acta       Date:  1970-07-07

10.  A hemodynamic comparison of dopamine and isoproterenol in patients in shock.

Authors:  R C Talley; L I Goldberg; C E Johnson; J L McNay
Journal:  Circulation       Date:  1969-03       Impact factor: 29.690

View more
  10 in total

1.  Introduction of Robert J. Lefkowitz.

Authors:  Ralph Snyderman
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

2.  The beta-adrenoceptor-adenylate cyclase complex. From model to biochemical reality.

Authors:  A P Ijzerman; H Timmerman
Journal:  Pharm Weekbl Sci       Date:  1986-08-22

3.  Identification of the cardiac beta-adrenergic receptor protein: solubilization and purification by affinity chromatography.

Authors:  R J Lefkowitz; E Haber; D O'Hara
Journal:  Proc Natl Acad Sci U S A       Date:  1972-10       Impact factor: 11.205

4.  Editorial: The pharmacology and therapeutic use of beta-adrenergic receptor blocking drugs in cardiovascular disease.

Authors:  D C Harrison
Journal:  Drugs       Date:  1974       Impact factor: 9.546

5.  Catecholamine binding to the beta-adrenergic receptor.

Authors:  R J Lefkowitz; L T Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Epinephrine binding to the catecholamine receptor and activation of the adenylate cyclase in erythrocyte membranes (hormone receptor- -adrenergic receptor-cyclic AMP-turkey).

Authors:  M Schramm; H Feinstein; E Naim; E Lang; M Lasser
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

7.  The binding characteristics and number of beta-adrenergic receptors on the turkey erythrocyte.

Authors:  A Levitzki; D Atlas; M L Steer
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

8.  Specific leukocyte receptors for small endogenous hormones. Detection by cell binding to insolubilized hormone preparations.

Authors:  Y Weinstein; K L Melmon; H R Bourne; M Sela
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

9.  Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.

Authors:  R W Alexander; L T Williams; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

10.  Conceptual Progress for the Improvements in the Selectivity and Efficacy of G Protein-Coupled Receptor Therapeutics: An Overview.

Authors:  Kyeong-Man Kim
Journal:  Biomol Ther (Seoul)       Date:  2017-01-01       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.